This study acknowledges the aspect of a faster and more precise response to radiotherapy, confirming international studies about p16 and HPV-positive oropharyngeal cancer and the need to rethink the radiation protocols for OPC HPV+ [8,10,34,35]. The gene discussed is CDKN2A; the disease is oropharynx cancer.